Serum FGF21 is found to be elevated in NAFLD patients, as compared to healthy subjects, and correlates with hepatic fat content and the degree of liver steatosis4, 10, 11, 12. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.